Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Current Cardiology Reports
Published in: Current Cardiology Reports 4/2020

01-04-2020 | Sleep Apnea | Ischemic Heart Disease (D Mukherjee, Section Editor)

Effects of Sleep Duration on Cardiovascular Events

Authors: Adeel Ahmad, S. Claudia Didia

Published in: Current Cardiology Reports | Issue 4/2020

Login to get access

Abstract

Purpose of Review

Sleep is an essential component of human health, and suboptimal sleep duration has been associated with increased cardiovascular morbidity and mortality. This review summarizes physiological and pathological effects of sleep duration on the cardiovascular system.

Recent Findings

Both decreased and increased duration of sleep lead to increased cardiovascular mortality and has a U-shaped curve. Sleep apnea is an independent risk factor for atherosclerosis and hypertension, and its treatment with continuous positive airway pressure (CPAP) results in increased survival.

Summary

Estimated sleep duration of 6–8 h is associated with decreased mortality and major cardiovascular events and should be addressed by clinicians during routine visits.
Literature
1.
Jike M, Itani O, Watanabe N, Buysse DJ, Kaneita Y. Long sleep duration and health outcomes: a systematic review, meta-analysis and meta-regression. Sleep Med Rev. 2018;39:25–36.CrossRefPubMed
2.
Carskadon MA. Normal Human Sleep: An overview. Philidelphia: Saunders; 2000.
3.
4.
Consensus Conference P, et al. Joint Consensus statement of the American Academy of Sleep Medicine and Sleep Research Society on the recommended amount of sleep for a healthy adult: methodology and discussion. J Clin Sleep Med. 2015;11(8):931–52.CrossRef
5.
Hirshkowitz M, Whiton K, Albert SM, Alessi C, Bruni O, DonCarlos L, et al. National Sleep Foundation’s updated sleep duration recommendations: final report. Sleep Health. 2015;1(4):233–43.CrossRefPubMed
6.
Liu Y, et al. Prevalence of healthy sleep duration among adults--United States, 2014. MMWR Morb Mortal Wkly Rep. 2016;65(6):137–41.CrossRefPubMed
7.
Peppard PE, Young T, Barnet JH, Palta M, Hagen EW, Hla KM. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013;177(9):1006–14.CrossRefPubMedPubMedCentral
8.
9.
Li X, Lin L, Lv L, Pang X, du S, Zhang W, et al. U-shaped relationships between sleep duration and metabolic syndrome and metabolic syndrome components in males: a prospective cohort study. Sleep Med. 2015;16(8):949–54.CrossRefPubMed
10.
Kim JY, Yadav D, Ahn SV, Koh SB, Park JT, Yoon J, et al. A prospective study of total sleep duration and incident metabolic syndrome: the ARIRANG study. Sleep Med. 2015;16(12):1511–5.CrossRefPubMed
11.
Somers VK, et al. Sympathetic-nerve activity during sleep in normal subjects. N Engl J Med. 1993;328(5):303–7.CrossRefPubMed
12.
Siobhan Banks JD, Basner M, and Dinges DF, Effects of sleep deprivation, in principles and practice of sleep medicine. 2017, Elsevier.
13.
14.
Hijmans JG, Levy M, Garcia V, Lincenberg GM, Diehl KJ, Greiner JJ, et al. Insufficient sleep is associated with a pro-atherogenic circulating microRNA signature. Exp Physiol. 2019;104(6):975–82.CrossRefPubMedPubMedCentral
15.
Bain AR, Weil BR, Diehl KJ, Greiner JJ, Stauffer BL, DeSouza C. Insufficient sleep is associated with impaired nitric oxide-mediated endothelium-dependent vasodilation. Atherosclerosis. 2017;265:41–6.CrossRefPubMed
16.
Grandner MA, Sands-Lincoln MR, Pak VM, Garland SN. Sleep duration, cardiovascular disease, and proinflammatory biomarkers. Nat Sci Sleep. 2013;5:93–107.CrossRefPubMedPubMedCentral
17.
Boudjeltia KZ, Faraut B, Esposito MJ, Stenuit P, Dyzma M, Antwerpen PV, et al. Temporal dissociation between myeloperoxidase (MPO)-modified LDL and MPO elevations during chronic sleep restriction and recovery in healthy young men. PLoS One. 2011;6(11):e28230.CrossRefPubMed
18.
Faraut B, Boudjeltia KZ, Vanhamme L, Kerkhofs M. Immune, inflammatory and cardiovascular consequences of sleep restriction and recovery. Sleep Med Rev. 2012;16(2):137–49.CrossRefPubMed
19.
Weil BR, et al. Short sleep duration is associated with enhanced endothelin-1 vasoconstrictor tone. Can J Physiol Pharmacol. 2010;88(8):777–81.CrossRefPubMed
20.
Chouchou F, et al. Sympathetic overactivity due to sleep fragmentation is associated with elevated diurnal systolic blood pressure in healthy elderly subjects: the PROOF-SYNAPSE study. Eur Heart J. 2013;34(28):2122–31, 2131a.CrossRefPubMed
21.
Dettoni JL, et al. Cardiovascular effects of partial sleep deprivation in healthy volunteers. J Appl Physiol (1985). 2012;113(2):232–6.CrossRef
22.
Sauvet F, et al. Effect of acute sleep deprivation on vascular function in healthy subjects. J Appl Physiol (1985). 2010;108(1):68–75.CrossRef
23.
Zhong X, et al. Increased sympathetic and decreased parasympathetic cardiovascular modulation in normal humans with acute sleep deprivation. J Appl Physiol (1985). 2005;98(6):2024–32.CrossRef
24.
Taheri S, Lin L, Austin D, Young T, Mignot E. Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index. PLoS Med. 2004;1(3):e62.CrossRefPubMedPubMedCentral
25.
Cappuccio FP, Cooper D, D'Elia L, Strazzullo P, Miller MA. Sleep duration predicts cardiovascular outcomes: a systematic review and meta-analysis of prospective studies. Eur Heart J. 2011;32(12):1484–92.CrossRefPubMed
26.
Tuomilehto H, Peltonen M, Partinen M, Lavigne G, Eriksson JG, Herder C, et al. Sleep duration, lifestyle intervention, and incidence of type 2 diabetes in impaired glucose tolerance: the Finnish diabetes prevention study. Diabetes Care. 2009;32(11):1965–71.CrossRefPubMedPubMedCentral
27.
Cappuccio FP, Stranges S, Kandala NB, Miller MA, Taggart FM, Kumari M, et al. Gender-specific associations of short sleep duration with prevalent and incident hypertension: the Whitehall II study. Hypertension. 2007;50(4):693–700.CrossRefPubMed
28.
Gangwisch JE, Heymsfield SB, Boden-Albala B, Buijs RM, Kreier F, Pickering TG, et al. Short sleep duration as a risk factor for hypertension: analyses of the first National Health and Nutrition Examination Survey. Hypertension. 2006;47(5):833–9.CrossRefPubMed
29.
Haack M, Serrador J, Cohen D, Simpson N, Meier-Ewert H, Mullington JM. Increasing sleep duration to lower beat-to-beat blood pressure: a pilot study. J Sleep Res. 2013;22(3):295–304.CrossRefPubMed
30.
Cakici M, Dogan A, Cetin M, Suner A, Caner A, Polat M, et al. Negative effects of acute sleep deprivation on left ventricular functions and cardiac repolarization in healthy young adults. Pacing Clin Electrophysiol. 2015;38(6):713–22.CrossRefPubMed
31.
Ozer O, Ozbala B, Sari I, Davutoglu V, Maden E, Baltaci Y, et al. Acute sleep deprivation is associated with increased QT dispersion in healthy young adults. Pacing Clin Electrophysiol. 2008;31(8):979–84.CrossRefPubMed
32.
Morovatdar N, Ebrahimi N, Rezaee R, Poorzand H, Bayat Tork MA, Sahebkar A. Sleep duration and risk of atrial fibrillation: a systematic review. J Atr Fibrillation. 2019;11(6):2132.CrossRefPubMedPubMedCentral
33.
Ayas NT, White DP, Manson JE, Stampfer MJ, Speizer FE, Malhotra A, et al. A prospective study of sleep duration and coronary heart disease in women. Arch Intern Med. 2003;163(2):205–9.CrossRefPubMed
34.
Barger LK, et al. Obstructive Sleep Apnea, Shiftwork, and the risk of adverse cardiovascular events in patients after an acute coronary syndrome. J Am Heart Assoc. 2017;6(10).
35.
Chandola T, Ferrie JE, Perski A, Akbaraly T, Marmot MG. The effect of short sleep duration on coronary heart disease risk is greatest among those with sleep disturbance: a prospective study from the Whitehall II cohort. Sleep. 2010;33(6):739–44.CrossRefPubMedPubMedCentral
36.
Liu Y, et al. Sleep duration and chronic diseases among U.S. adults age 45 years and older: evidence from the 2010 behavioral risk factor surveillance system. Sleep. 2013;36(10):1421–7.CrossRefPubMedPubMedCentral
37.
Kwok CS, et al. Self-reported sleep duration and quality and cardiovascular disease and mortality: a dose-response meta-analysis. J Am Heart Assoc. 2018;7(15):e008552.CrossRefPubMedPubMedCentral
38.
•• Wang C, et al. Association of estimated sleep duration and naps with mortality and cardiovascular events: a study of 116 632 people from 21 countries. Eur Heart J. 2019;40(20):1620–9 A very large study showing both increased and decreased duration of sleep is associated with not only increased cardiovascular event but also mortality.CrossRefPubMed
39.
Thomson CA, Morrow KL, Flatt SW, Wertheim BC, Perfect MM, Ravia JJ, et al. Relationship between sleep quality and quantity and weight loss in women participating in a weight-loss intervention trial. Obesity (Silver Spring). 2012;20(7):1419–25.CrossRef
40.
• Al Khatib HK, et al. Sleep extension is a feasible lifestyle intervention in free-living adults who are habitually short sleepers: a potential strategy for decreasing intake of free sugars? A randomized controlled pilot study. Am J Clin Nutr. 2018;107(1):43–53 Although a short-term study but it showed that sleep extension is possible with behvioral help for sleep hygeine and increase in sleep duration showed decreased intake of sugars and fat, major factors in development of metabolic syndrome.CrossRefPubMedPubMedCentral
41.
Tasali E, Chapotot F, Wroblewski K, Schoeller D. The effects of extended bedtimes on sleep duration and food desire in overweight young adults: a home-based intervention. Appetite. 2014;80:220–4.CrossRefPubMedPubMedCentral
42.
Scheer FA, van Montfrans G, van Someren E, Mairuhu G, Buijs RM. Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension. 2004;43(2):192–7.CrossRefPubMed
43.
Aurora RN, Crainiceanu C, Gottlieb DJ, Kim JS, Punjabi NM. Obstructive sleep apnea during REM sleep and cardiovascular disease. Am J Respir Crit Care Med. 2018;197(5):653–60.CrossRefPubMedPubMedCentral
44.
Floras JS. Sleep apnea and cardiovascular disease: an enigmatic risk factor. Circ Res. 2018;122(12):1741–64.CrossRefPubMed
45.
Young T, Palta M, Dempsey J, Peppard PE, Nieto FJ, Hla KM. Burden of sleep apnea: rationale, design, and major findings of the Wisconsin sleep cohort study. WMJ. 2009;108(5):246–9.PubMedPubMedCentral
46.
Pack AI, Gislason T. Obstructive sleep apnea and cardiovascular disease: a perspective and future directions. Prog Cardiovasc Dis. 2009;51(5):434–51.CrossRefPubMed
47.
Arnardottir ES, Mackiewicz M, Gislason T, Teff KL, Pack AI. Molecular signatures of obstructive sleep apnea in adults: a review and perspective. Sleep. 2009;32(4):447–70.CrossRefPubMedPubMedCentral
48.
Lisan Q, van Sloten T, Marques Vidal P, Haba Rubio J, Heinzer R, Empana JP. Association of positive airway pressure prescription with mortality in patients with obesity and severe obstructive sleep apnea: the sleep heart health study. JAMA Otolaryngol Head Neck Surg. 2019;145(6):509–15.CrossRefPubMedPubMedCentral
Metadata
Title
Effects of Sleep Duration on Cardiovascular Events
Authors
Adeel Ahmad
S. Claudia Didia
Publication date
01-04-2020
Publisher
Springer US
Keyword
Sleep Apnea
Published in
Current Cardiology Reports / Issue 4/2020
Print ISSN: 1523-3782
Electronic ISSN: 1534-3170
DOI
https://doi.org/10.1007/s11886-020-1271-0

Other articles of this Issue 4/2020

Current Cardiology Reports 4/2020 Go to the issue

Ischemic Heart Disease (D Mukherjee, Section Editor)

Sex Differences in Coronary Artery Calcium and Long-term CV Mortality

Ischemic Heart Disease (D Mukherjee, Section Editor)

The Clinical Significance of Physiological Assessment of Residual Ischemia After Percutaneous Coronary Intervention

Ischemic Heart Disease (D Mukherjee, Section Editor)

Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment

Nuclear Cardiology (V Dilsizian, Section Editor)

How Do PET Myocardial Blood Flow Reserve and FFR Differ?

Ischemic Heart Disease (D Mukherjee, Section Editor)

Association Between Obesity and Cardiovascular Outcomes: Updated Evidence from Meta-analysis Studies

Ischemic Heart Disease (D Mukherjee, Section Editor)

Current Use and Trends in Unprotected Left Main Coronary Artery Percutaneous Intervention

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24 to hear Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits